EMBECTA CORP. Increase (Decrease) in Accounts Payable
EMBECTA CORP. (EMBC) reported Increase (Decrease) in Accounts Payable of $41.40 million for the 9-month period ending 2022-06-30, per its 10-Q filed 2022-08-15.
Discontinued › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInAccountsPayable · last filed 2022-08-15
- EMBECTA CORP. increase (decrease) in accounts payable for the quarter ending 2022-06-30 was $44.30M, a 705.45% increase year-over-year.
- EMBECTA CORP. increase (decrease) in accounts payable for the quarter ending 2022-03-31 was -$6.80M.
- EMBECTA CORP. increase (decrease) in accounts payable for the quarter ending 2021-12-31 was $3.90M.
- EMBECTA CORP. increase (decrease) in accounts payable for the quarter ending 2021-06-30 was $5.50M.
| Period end | Increase (Decrease) in Accounts Payable 3 month | Increase (Decrease) in Accounts Payable 6 month | Increase (Decrease) in Accounts Payable 9 month |
|---|---|---|---|
| 2022-06-30 | $44.30M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | $37.50M derived: sum of 2 quarters · filed 2022-08-15 | $41.40M 10-Q · filed 2022-08-15 |
| 2022-03-31 | -$6.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$2.90M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $3.90M 10-Q · filed 2022-03-16 | ||
| 2021-06-30 | $5.50M derived: 10-Q 9 month − 10-Q 6 month · filed 2022-08-15 | -$300.00K derived: sum of 2 quarters · filed 2022-08-15 | -$8.30M 10-Q · filed 2022-08-15 |
| 2021-03-31 | -$5.80M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-05-13 | -$13.80M 10-Q · filed 2022-05-13 | |
| 2020-12-31 | -$8.00M 10-Q · filed 2022-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| SHOULDER INNOVATIONS, INC. (SI) | United States | $0.355B | |
| Orchestra BioMed Holdings, Inc. (OBIO) | United States | $0.356B | -4.39 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| ORASURE TECHNOLOGIES INC (OSUR) | United States | $0.272B | -6.26 |
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Orthofix Medical Inc. (OFIX) | $0.373B | ||
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |